Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-

-

 
WKN: A14VMC / Name: Celyad / Stock / Biotechnology & Medical Research / Small Cap /
Your prediction

Celyad SA ADR Stock

Our community identified positive and negative aspects for Celyad SA ADR stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Celyad SA ADR stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.

Pros and Cons of Celyad SA ADR in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Celyad SA ADR vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Celyad SA ADR - - - - - - -
Oxurion NV - 0.000% 0.000% -97.778% -83.333% -99.996% -99.997%
Cardio3 Biosciences S.A. -0.180% 0.000% -10.129% -54.627% -18.986% -94.656% -98.468%
Chromadex Corp 3.160% -10.056% -9.551% 157.600% 140.299% -47.642% -